Birgit Watson - Search Results

Year	Number of Results
2014	1
2015	1
2017	2
2018	1
2021	2
2022	1
2024	0

1

A Pharmacokinetic Dose-Optimization Study of Cabotegravir and Bictegravir in a Mouse Pregnancy Model.

Mohan H, Atkinson K, Watson B, Brumme CJ, Serghides L. Mohan H, et al. Among authors: watson b. Pharmaceutics. 2022 Aug 24;14(9):1761. doi: 10.3390/pharmaceutics14091761. Pharmaceutics. 2022. PMID: 36145509 Free PMC article.

2

Untimed Efavirenz Drug Levels After Switching From Brand to Generic Formulations: A Short Communication.

Watson BE, Atkinson K, Auyeung K, Baynes KA, Lepik KJ, Toy J, Sereda P, Barrios R, Brumme CJ. Watson BE, et al. Ther Drug Monit. 2021 Oct 1;43(5):701-705. doi: 10.1097/FTD.0000000000000876. Ther Drug Monit. 2021. PMID: 33560098

3

Oral administration of tipranavir with long-chain triglyceride results in moderate intestinal lymph targeting but no efficient delivery to HIV-1 reservoir in mesenteric lymph nodes.

Chu Y, Qin C, Feng W, Sheriston C, Jane Khor Y, Medrano-Padial C, Watson BE, Chan T, Ling B, Stocks MJ, Fischer PM, Gershkovich P. Chu Y, et al. Among authors: watson be. Int J Pharm. 2021 Jun 1;602:120621. doi: 10.1016/j.ijpharm.2021.120621. Epub 2021 Apr 21. Int J Pharm. 2021. PMID: 33892057

4

Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens.

Kala S, Watson B, Zhang JG, Papp E, Guzman Lenis M, Dennehy M, Cameron DW, Harrigan PR, Serghides L. Kala S, et al. Among authors: watson b. Antiviral Res. 2018 Nov;159:45-54. doi: 10.1016/j.antiviral.2018.09.008. Epub 2018 Sep 17. Antiviral Res. 2018. PMID: 30236532

5

HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study.

Harris M, Ganase B, Watson B, Harrigan PR, Montaner JSG, Hull MW. Harris M, et al. Among authors: watson b. AIDS Res Ther. 2017 Nov 2;14(1):59. doi: 10.1186/s12981-017-0185-4. AIDS Res Ther. 2017. PMID: 29096670 Free PMC article. Clinical Trial.

6

Efficacy and safety of "unboosting" atazanavir in a randomized controlled trial among HIV-infected patients receiving tenofovir DF.

Harris M, Ganase B, Watson B, Hull MW, Guillemi SA, Zhang W, Saeedi R, Harrigan PR. Harris M, et al. Among authors: watson b. HIV Clin Trials. 2017 Jan;18(1):39-47. doi: 10.1080/15284336.2016.1271503. Epub 2017 Jan 9. HIV Clin Trials. 2017. PMID: 28067119 Clinical Trial.

7

Post-marketing experience with nevirapine extended release (XR) tablets: effectiveness and tolerability in a population-based cohort in British Columbia, Canada.

Lepik KJ, Yip B, McGovern RA, Ding E, Nohpal A, Watson BE, Toy J, Akagi L, Harrigan PR, Moore DM, Hogg RS, Montaner JS, Barrios R. Lepik KJ, et al. Among authors: watson be. Antivir Ther. 2015;20(7):721-30. doi: 10.3851/IMP2908. Epub 2014 Oct 27. Antivir Ther. 2015. PMID: 25960569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

7 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year